sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Bovine Mastitis Market by Product (Antibiotics, Other), by Route of administration (Intramammary, Systemic), by Application (Veterinary Hospitals and Clinics, On-site Treatment): Global Opportunity Analysis and Industry Forecast, 2023-2031

Bovine Mastitis Market by Product (Antibiotics, Other), by Route of...

Home / Categories / Healthcare
Bovine Mastitis Market by Product (Antibiotics, Other), by Route of administration (Intramammary, Systemic), by Application (Veterinary Hospitals and Clinics, On-site Treatment): Global Opportunity Analysis and Industry Forecast, 2023-2031
Bovine Mastitis Market by Product...
Report Code
RO1/128/1033

Publish Date
26/May/2023

Pages
200
PRICE
$ 4900/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 5400/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 8700/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
The global bovine mastitis market revenue was around US$ 0.94 billion in 2021 and is estimated to reach US$ 1.09 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period from 2022 to 2031.

Bovine mastitis is an inflammatory response of the mammary gland's udder tissue due to microbial infections or physical damage. It is regarded as the most common illness that causes financial loss in the dairy sector because of decreased yield and poor milk quality.

Factors Influencing Market Growth

The rising incidence of cow injuries and the prevalence of bovine mastitis propels the market growth.

Increase in dairy farms and the production of dairy products. Thus it is anticipated to drive the market growth.

Rising government and non-government initiatives as well as increased funding for veterinary treatment. Such factors boost the market.

Several major market players are concentrating on R&D operations to produce drugs for bovine mastitis as the growing number of dairy animals, which also contributes to the market expansion

Many key market players are focusing on R&D activities to develop drugs for bovine mastitis as the dairy animal population is increasing, which also contributes to market growth.

Study of the COVID-19 Pandemic

The COVID-19 pandemic had a negative impact on bovine mastitis on the market. Due to the lockdown enacted by the government, the supply chain for farms and the dairy industry was halted. During the pandemic, the whole healthcare sector has concentrated on items that save lives and are related to COVID-19, which limits the treatment of cow mastitis. The healthcare industry has undergone restructuring to provide safer healthcare facilities. Thus, it is projected that the market will expand in post-pandemic circumstances.

Regional Insights

Asia-Pacific accounted for the largest share of the market. Due to its established animal healthcare infrastructure, breakthroughs in treating bovine mastitis, and the region's abundance of dairy farms. These factors fuel the market growth in this region.

However, LAMEA is anticipated to develop significant growth because of an increase in product releases there, an increase in spending healthcare on care for animals, and a rise in the number of dairy farms. Such factors drive the market in this region.

Leading Competitors
The leading competitors in the global bovine mastitis market are:
Armenta Ltd
Boehringer Ingelheim Gmbh
Ecolab Inc
Forte Healthcare Ltd
Huvepharma NV
Merck KGaA
Mileutis Ltd
Neogen Corporation
Thermo Fisher Scientific Inc
Zoetis Inc
Others
Segmentation Analysis
The global bovine mastitis market segmentation focuses on Product, Route of Administration, Application and Region.
Segmentation based on Product
Antibiotics
Other
Segmentation based on Route of Administration
Intramammary
Systemic
Segmentation based on Application
Veterinary Hospitals and Clinics
? Mild Cases
? Moderate Cased
? Severe Cases
On-site Treatment
? Mild Cases
? Moderate Cases
? Severe Cases
Segmentation based on Region
North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific

Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA

South America
Brazil
Argentina
Rest of South America

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com